UBS ASSET MANAGEMENT AMERICAS INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,148,512
+46.7%
46,717
+19.6%
0.00%0.0%
Q2 2023$1,464,4150.0%39,0510.0%0.00%0.0%
Q1 2023$1,464,415
+18.5%
39,051
-11.4%
0.00%0.0%
Q4 2022$1,235,318
-99.9%
44,087
-5.0%
0.00%0.0%
Q3 2022$1,304,486,000
-21.7%
46,423
-3.1%
0.00%0.0%
Q2 2022$1,665,919,000
+7.3%
47,885
+10.8%
0.00%0.0%
Q1 2022$1,552,100,000
+95.9%
43,234
+27.1%
0.00%
Q4 2021$792,231,000
+22.5%
34,0160.0%0.00%
Q3 2021$646,646,000
-26.8%
34,016
-22.4%
0.00%
Q2 2021$883,230,000
+17.3%
43,811
+6.6%
0.00%
Q1 2021$752,712,000
-8.9%
41,0870.0%0.00%
Q4 2020$826,260,000
+7.3%
41,0870.0%0.00%
Q3 2020$770,382,000
-8.6%
41,087
+9.4%
0.00%
-100.0%
Q2 2020$843,305,000
+28.7%
37,547
-15.0%
0.00%
Q1 2020$655,468,000
-88.4%
44,169
-85.0%
0.00%
-100.0%
Q4 2019$5,667,383,000
-2.0%
293,799
+0.8%
0.00%
-25.0%
Q3 2019$5,781,456,000
-5.9%
291,551
+0.1%
0.00%0.0%
Q2 2019$6,145,755,000
+1.8%
291,130
-1.5%
0.00%0.0%
Q1 2019$6,036,616,000
+5.3%
295,478
+2.6%
0.00%
-20.0%
Q4 2018$5,732,493,000
-2.9%
288,065
-6.1%
0.01%
+25.0%
Q3 2018$5,902,293,000
+30.0%
306,772
+3.1%
0.00%
+33.3%
Q2 2018$4,539,667,000
-28.5%
297,488
-12.2%
0.00%
-40.0%
Q1 2018$6,352,183,000
-17.8%
338,783
-15.6%
0.01%
-28.6%
Q4 2017$7,725,571,000
-8.3%
401,537
-14.8%
0.01%
-12.5%
Q3 2017$8,422,917,000
+29.9%
471,344
+29.9%
0.01%
+33.3%
Q2 2017$6,482,234,000
+199.3%
362,947
+143.0%
0.01%
+200.0%
Q1 2017$2,165,938,000
+84639.4%
149,375
+7.6%
0.00%
-33.3%
Q4 2016$2,556,000
-9.8%
138,775
-7.1%
0.00%0.0%
Q3 2016$2,835,000
-14.6%
149,448
-27.4%
0.00%
-25.0%
Q2 2016$3,320,000
-0.2%
205,975
-25.7%
0.00%0.0%
Q1 2016$3,328,000
-7.3%
277,294
+10.0%
0.00%0.0%
Q4 2015$3,589,000
-41.2%
252,199
-51.7%
0.00%
-42.9%
Q3 2015$6,104,000
-21.6%
522,178
+17.9%
0.01%0.0%
Q2 2015$7,786,000
+67.7%
442,855
+42.7%
0.01%
+75.0%
Q1 2015$4,644,000310,4170.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders